Clinical trials for Thalassaemia

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Thalassaemia. For all clinical trials, go to clinical trials search

This list shows clinical trials for Thalassaemia

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Thalassaemia
Title Recruitment status Location
Antenatal screening for haemoglobinopathies in primary care: a cluster randomised trial to inform a simulation model Not Recruiting United Kingdom
Pilot of oral Sildenafil for the treatment of Pulmonary Hypertension in Thalassaemia with comparison to controls. - Pulmonary Hypertension (PHT)Study Not Recruiting United Kingdom
A randomised, comparative, open label phase III trial on efficacy and safety of long-term treatment with ICL670 (5 to 40 mg/kg/day) in comparison with deferoxamine (DFO) (20 to 60 mg/kg/day) in ß-thalassaemia patients with transfusional haemosiderosis Not Recruiting United Kingdom
The effect of vit D supplement on ejection fraction, ferritin and hypertention in beta-thalassaemia major patients Recruiting Iran, Islamic Republic Of
Evaluation of hemoglobin in pregnant women with thalassemia minor and intermedia Recruiting Iran, Islamic Republic Of
To assess compliance, efficacy and satisfaction with two different formulation of deferasirox in patients with transfusion-dependent beta-thalassemia Recruiting Iran, Islamic Republic Of
The Effect of Orem’s Self-Care Model on Quality Of Life of Patients with talasemia major Recruiting Iran, Islamic Republic Of
An interventional study to evaluate the effects of dosages on the Pharmacokinetics (PK, the measure of how the human body processes a substance), Pharmacodynamics (PD, the measure of what a substance does to the human body), Tolerability (how well a substance is tolerated by participants), and Safety of different dosages of IONIS-TMPRSS6-Lrx when given to healthy participants as either a single subcutaneous (SC, an injection just under the skin) dose, or as multiple SC doses. Not recruiting Australia
Evaluating the Efficacy of Deferasirox in Transfusion Dependent Chronic Anaemias (Myelodysplastic Syndrome, Beta-thalassaemia Patients) With Chronic Iron Overload Not recruiting Hungary
Evaluation of effects of aqueous extract of Iranian oak (Quercus brantii) on antioxidant capacity and stress oxidative of thalassemia patients Not Recruiting Iran, Islamic Republic Of

Page last reviewed: 17/05/2016

Next review due: 01/05/2019